Basel, October 6, 2017 - Alcon, the global leader in eye care and a division of Novartis, has achieved European CE Mark for the Clareon ® IOL with the AutonoMe(TM) delivery system. AutonoMe(TM) is the ...

Cataract surgery continues to evolve and advance in terms of technology, along with improved techniques, to offer a final result of augmented visual quality and faster visual recovery for our patients ...

Alcon, the global leader in eye care and a division of Novartis, has achieved European CE Mark for the Clareon IOL with the AutonoMe delivery system. AutonoMe is the first-and-only automated, ...

SEATTLE — IOL makers have introduced lens-specific injector systems for their most popular models, allowing more cataract surgeons access to the ease of using shooters. According to Andy Stapars, ...

TORONTO, Feb. 1, 2021 /CNW/ - Alcon, the global leader in eye care, is pleased to announce a nationwide launch of the Clareon ® intraocular lens (IOL) with the AutonoMe ® delivery system in Canada.

(RTTNews) - Novartis AG (NVS) announced Friday that its eye care unit Alcon has achieved European CE Mark for the Clareon IOL with the AutonoMe delivery system. Clareon AutonoMe is expected to be ...

CALGARY, Alberta - (NewMediaWire) - August 08, 2024 - Ocumetics Technology Corp. ("Ocumetics") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a pioneer in vision enhancement technology, is excited to ...

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...

We have read the article by Khokhar S et al 1 with a great interest. The authors have rightly compared two techniques in terms of wound enlargement, wound integrity, and incidence of Descemet’s ...

Novartis International AG / Alcon receives CE Mark for first-of-its-kind AutonoMe preloaded intraocular lens (IOL) delivery system with Clareon® IOL . Processed and transmitted by Nasdaq Corporate ...